These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 15713620)

  • 1. Phosphoinositide 3-kinase catalytic subunit deletion and regulatory subunit deletion have opposite effects on insulin sensitivity in mice.
    Brachmann SM; Ueki K; Engelman JA; Kahn RC; Cantley LC
    Mol Cell Biol; 2005 Mar; 25(5):1596-607. PubMed ID: 15713620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of phosphoinositide 3-kinase regulatory isoforms in development and actin rearrangement.
    Brachmann SM; Yballe CM; Innocenti M; Deane JA; Fruman DA; Thomas SM; Cantley LC
    Mol Cell Biol; 2005 Apr; 25(7):2593-606. PubMed ID: 15767666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Class IA phosphoinositide 3-kinases are obligate p85-p110 heterodimers.
    Geering B; Cutillas PR; Nock G; Gharbi SI; Vanhaesebroeck B
    Proc Natl Acad Sci U S A; 2007 May; 104(19):7809-14. PubMed ID: 17470792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Positive and negative roles of p85 alpha and p85 beta regulatory subunits of phosphoinositide 3-kinase in insulin signaling.
    Ueki K; Fruman DA; Yballe CM; Fasshauer M; Klein J; Asano T; Cantley LC; Kahn CR
    J Biol Chem; 2003 Nov; 278(48):48453-66. PubMed ID: 14504291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Divergent roles of the regulatory subunits of class IA PI3K.
    Kim CW; Lee JM; Park SW
    Front Endocrinol (Lausanne); 2023; 14():1152579. PubMed ID: 38317714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Positive and negative regulation of phosphoinositide 3-kinase-dependent signaling pathways by three different gene products of the p85alpha regulatory subunit.
    Ueki K; Algenstaedt P; Mauvais-Jarvis F; Kahn CR
    Mol Cell Biol; 2000 Nov; 20(21):8035-46. PubMed ID: 11027274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p50alpha/p55alpha phosphoinositide 3-kinase knockout mice exhibit enhanced insulin sensitivity.
    Chen D; Mauvais-Jarvis F; Bluher M; Fisher SJ; Jozsi A; Goodyear LJ; Ueki K; Kahn CR
    Mol Cell Biol; 2004 Jan; 24(1):320-9. PubMed ID: 14673165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Direct positive regulation of PTEN by the p85 subunit of phosphatidylinositol 3-kinase.
    Chagpar RB; Links PH; Pastor MC; Furber LA; Hawrysh AD; Chamberlain MD; Anderson DH
    Proc Natl Acad Sci U S A; 2010 Mar; 107(12):5471-6. PubMed ID: 20212113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased insulin sensitivity in mice lacking p85beta subunit of phosphoinositide 3-kinase.
    Ueki K; Yballe CM; Brachmann SM; Vicent D; Watt JM; Kahn CR; Cantley LC
    Proc Natl Acad Sci U S A; 2002 Jan; 99(1):419-24. PubMed ID: 11752399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p110beta is up-regulated during differentiation of 3T3-L1 cells and contributes to the highly insulin-responsive glucose transport activity.
    Asano T; Kanda A; Katagiri H; Nawano M; Ogihara T; Inukai K; Anai M; Fukushima Y; Yazaki Y; Kikuchi M; Hooshmand-Rad R; Heldin CH; Oka Y; Funaki M
    J Biol Chem; 2000 Jun; 275(23):17671-6. PubMed ID: 10748220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of the liver in glucose homeostasis in PI 3-kinase p85alpha-deficient mice.
    Aoki K; Matsui J; Kubota N; Nakajima H; Iwamoto K; Takamoto I; Tsuji Y; Ohno A; Mori S; Tokuyama K; Murakami K; Asano T; Aizawa S; Tobe K; Kadowaki T; Terauchi Y
    Am J Physiol Endocrinol Metab; 2009 Apr; 296(4):E842-53. PubMed ID: 19176357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of class IA PI3K signaling in muscle leads to impaired muscle growth, insulin response, and hyperlipidemia.
    Luo J; Sobkiw CL; Hirshman MF; Logsdon MN; Li TQ; Goodyear LJ; Cantley LC
    Cell Metab; 2006 May; 3(5):355-66. PubMed ID: 16679293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential regulation of the phosphoinositide 3-kinase and MAP kinase pathways by hepatocyte growth factor vs. insulin-like growth factor-I in myogenic cells.
    Halevy O; Cantley LC
    Exp Cell Res; 2004 Jul; 297(1):224-34. PubMed ID: 15194438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased P85alpha is a potent negative regulator of skeletal muscle insulin signaling and induces in vivo insulin resistance associated with growth hormone excess.
    Barbour LA; Mizanoor Rahman S; Gurevich I; Leitner JW; Fischer SJ; Roper MD; Knotts TA; Vo Y; McCurdy CE; Yakar S; Leroith D; Kahn CR; Cantley LC; Friedman JE; Draznin B
    J Biol Chem; 2005 Nov; 280(45):37489-94. PubMed ID: 16166093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of the retinal insulin receptor beta-subunit with the p85 subunit of phosphoinositide 3-kinase.
    Rajala RV; McClellan ME; Chan MD; Tsiokas L; Anderson RE
    Biochemistry; 2004 May; 43(19):5637-50. PubMed ID: 15134438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatic deletion of p110α and p85α results in insulin resistance despite sustained IRS1-associated phosphatidylinositol kinase activity.
    Chaudhari A; Ejeskär K; Wettergren Y; Kahn CR; Rotter Sopasakis V
    F1000Res; 2017; 6():1600. PubMed ID: 29983910
    [No Abstract]   [Full Text] [Related]  

  • 17. Phosphoinositide 3-kinase regulatory subunit p85alpha suppresses insulin action via positive regulation of PTEN.
    Taniguchi CM; Tran TT; Kondo T; Luo J; Ueki K; Cantley LC; Kahn CR
    Proc Natl Acad Sci U S A; 2006 Aug; 103(32):12093-7. PubMed ID: 16880400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PAQR3 modulates insulin signaling by shunting phosphoinositide 3-kinase p110α to the Golgi apparatus.
    Wang X; Wang L; Zhu L; Pan Y; Xiao F; Liu W; Wang Z; Guo F; Liu Y; Thomas WG; Chen Y
    Diabetes; 2013 Feb; 62(2):444-56. PubMed ID: 23086038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The p110beta isoform of phosphoinositide 3-kinase signals downstream of G protein-coupled receptors and is functionally redundant with p110gamma.
    Guillermet-Guibert J; Bjorklof K; Salpekar A; Gonella C; Ramadani F; Bilancio A; Meek S; Smith AJ; Okkenhaug K; Vanhaesebroeck B
    Proc Natl Acad Sci U S A; 2008 Jun; 105(24):8292-7. PubMed ID: 18544649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of phosphoinositide 3-OH kinase p110β in skeletal myogenesis.
    Matheny RW; Riddle-Kottke MA; Leandry LA; Lynch CM; Abdalla MN; Geddis AV; Piper DR; Zhao JJ
    Mol Cell Biol; 2015 Apr; 35(7):1182-96. PubMed ID: 25605332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.